SCHEMBL6555867

SCHEMBL6555867

N#CCCN(c1cc[c]cc1)c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.44
HSD17B10 Q99714 1/20 0.44
KCNA3 P22001 1/20 0.40
MLYCD O95822 1/20 0.40
SCN9A Q15858 4/20 0.39
GAA P10253 1/20 0.39
ALDH1A1 P00352 3/20 0.37
KCNH2 Q12809 2/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
LMNA P02545 1/20 0.37
MAPT P10636 1/20 0.37
CRHBP P24387 1/20 0.37
CRHR2 Q13324 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
MTNR1A P48039 1/20 0.36
MTNR1B P49286 1/20 0.36
POLB P06746 1/20 0.36
HTT P42858 1/20 0.35
RAB9A P51151 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL151399 0.92 USP2 (0.49) USP2HSD17B10KCNA3MLYCDSCN9A
SCHEMBL154388 0.80 KCNA3 (0.56) USP2HSD17B10KCNA3MLYCDSCN9A
SCHEMBL152086 0.78 KCNA3 (0.51) USP2HSD17B10KCNA3MLYCDSCN9A
SCHEMBL8010248 0.76 KCNH2 (0.57) KCNA3KCNH2
SCHEMBL21628965 0.76 MEN1 (0.44) HSD17B10ALDH1A1KCNH2MEN1KMT2A
SCHEMBL2323987 0.75 USP2 (0.53) USP2HSD17B10KCNA3MLYCDGAA
SCHEMBL6554137 0.75 TSHR (0.40) USP2HSD17B10MLYCDALDH1A1MEN1
SCHEMBL11792818 0.75 ALDH1A1 (0.42) USP2HSD17B10KCNA3MLYCDSCN9A
SCHEMBL6555348 0.75 POLB (0.48) USP2HSD17B10GAAALDH1A1KCNH2
SCHEMBL6827396 0.74 USP2 (0.47) USP2HSD17B10KCNA3MLYCDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1234007-B1 OLIGOMERIC METHINE DYES CLARIANT FINANCE BVI LTD (VG) 2004-02-18 EP disclosed
EP-1234007-A1 OLIGOMERIC METHINE DYES Clariant Finance (BVI) Limited (VG) 2002-08-28 EP disclosed
US-20010012899-A1 Oligomeric methine dyes CLARIANT FINANCE ( BVI) LIMITED 2001-08-09 US disclosed
WO-2001036543-A1 OLIGOMERIC METHINE DYES CLARIANT FINANCE (BVI) LIMITED (VG) 2001-05-25 WO disclosed
US-4256458-A DIMERIC PYRIDINIUM DYES BASF AKTIENGESELLSCHAFT (DE) 1981-03-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010012899-A1 Oligomeric methine dyes INMT, DDT, DDC USP2 3142/4885HSD17B10 3464/4885KCNA3 2523/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.